AMERICAN SOCIETY OF HEMATOLOGY INC
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$358,392,943
Investments
57%
Property, Plant, & Equipment (net)
16%
Other Assets
13%
Cash & Equivalents
10%
Receivables (Non-Related)
3%
Prepaid Expenses
2%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$93,808,241
Notes Payable / Debt (Non-Related)
45%
Deferred Revenue
30%
Grants Payable
17%
Payables & Accruals
8%
Other Liabilities
<1%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$43,623,398
$35,378,614
-19%
Receivables (Non-Related)
$10,172,931
$9,485,441
-7%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$5,726,649
$6,543,045
+14%
Investments
$181,561,835
$206,053,340
+13%
Property, Plant, & Equipment (net)
$52,673,134
$56,009,004
+6%
Other Assets
$37,776,989
$44,923,499
+19%
Total Assets
$331,534,936
$358,392,943
+8%
Liabilities
2023
2024
Change
Payables & Accruals
$7,179,245
$7,753,658
+8%
Grants Payable
$15,661,659
$15,568,571
-1%
Deferred Revenue
$27,021,282
$28,446,934
+5%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$43,870,289
$42,013,232
-4%
Related-Party Payables
-
-
-
Other Liabilities
$25,846
$25,846
+0%
Total Liabilities
$93,758,321
$93,808,241
+0%
Net assets
2023
2024
Change
Restricted Net Assets
$14,108,523
$14,572,411
+3%
Unrestricted Net Assets
$223,668,092
$250,012,291
+12%
Net assets
2023
2024
Change
Net assets
+$237,776,615
+$264,584,702
+11%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)